Top

Published in:

01-06-2001

Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada)

Authors: Christy G. Woolcott, Kristan J. Aronson, Wedad M. Hanna, Sandip K. SenGupta, David R. McCready, Ernest E. Sterns, Anthony B. Miller

Published in: Cancer Causes & Control | Issue 5/2001

Title: Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada)
Authors: Christy G. Woolcott
Kristan J. Aronson
Wedad M. Hanna
Sandip K. SenGupta
David R. McCready
Ernest E. Sterns
Anthony B. Miller
Publication date: 01-06-2001
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 5/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/A:1011289905751

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2001

Colorectal cancer following tamoxifen therapy for breast cancer (United States)

The contribution of cigarette smoking to bladder cancer in women (pooled European data)

Mouthwash in the etiology of oral cancer in Puerto Rico

Assessing phytoestrogen exposure via a food-frequency questionnaire

Reduced sun exposure and tanning in children after 2 years of a school-based intervention (Australia)

Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer